Regardless of the mechanism responsible, the adverse effect of MCT8 on the viability of cytotrophoblast cells is consistent with our hypothesis that the increased placental expression of MCT8 in IUGR pregnancies may contribute to the pathophysiology of decreased placental size and, hence, fetal size [6], [23], [24]. This evidence concerns the gene SLC16A2 and fetal growth restriction.